SEC Form 4 · accession 0000884731-17-000002
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bollag
Officer — Sr. VP, Reg. Affairs & Quality
Period of report
Jan 9, 2017
Accepted (ET)
Jan 10, 2017 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2017 | M | 32,000 | $7.82 | A | 161,404 | D | |
| Common Stock | Jan 9, 2017 | S | 32,000 | $23.78 | D | 129,404 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $7.82 | Jan 9, 2017 | M | 32,000 | D | Apr 1, 2012 | Apr 1, 2021 | Common Stock | 32,000 | 0 | D |
Explanation of responses
- F1Shares were acquired from exercise of an outstanding stock option pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2016
- F2Shares were sold pursuant to a Rule 10b5-1 trading plan dated June 15, 2016